Checkpoint Therapeutics, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
Beryl Capital Management and affiliates report 0% beneficial ownership in Checkpoint Therapeutics, Inc., indicating a full divestment.